ACM
EXAS

American Capital Management’s Exact Sciences EXAS Stock Holding History

American Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23,290
Closed -$215K – 105
2015
Q4 		$215K Buy
+23,290
New +$217K 0.02% 103

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

American Capital Management's EXAS Position: Q1 2016 in Review

American Capital Management sold out of Exact Sciences (EXAS) in Q1 2016, closing a stake of 23,290 shares — an estimated $215K sold.

American Capital Management first reported a position in EXAS in Q4 2015 and held it in 1 quarter. The position peaked at $215K in Q4 2015. 167 funds tracked by Wall St. Rank hold EXAS as of Q1 2016.

  • American Capital Management reported no remaining Exact Sciences position as of Q1 2016 after selling out during the quarter.
  • American Capital Management sold 23,290 Exact Sciences shares in Q1 2016, an estimated $215K.
  • American Capital Management first reported a position in Exact Sciences in Q4 2015 and held it in 1 quarter.
  • American Capital Management's Exact Sciences position peaked at $215K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2016.

Based on American Capital Management's 13F filing for Q1 2016, filed 25 Apr 2016.